Literature DB >> 26883053

Evaluation and Targeted Therapy of Voiding Dysfunction in Children.

Lane S Palmer1.   

Abstract

Significant strides have been made over the past two decades in more precisely evaluating and managing children with voiding complaints. A thorough history should offer insight into the possible causes for the presenting complaints and this should be supplemented by physical examination, urine studies, and select imaging. Uroflowmetry and external sphincter electromyography with measurement of postvoid residual urine should allow for accurate diagnosis using categories offered by the International Children's Continence Society. This ability to make an accurate diagnosis should naturally lead to the use of treatment options (urotherapy, pharmacotherapy, biofeedback, and neuromodulation) that specifically target the responsible cause of the complaints rather than simply their symptoms.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26883053     DOI: 10.1016/j.urology.2016.02.002

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

Review 1.  The Role of Non-invasive Testing in Evaluation and Diagnosis of Pediatric Lower Urinary Tract Dysfunction.

Authors:  Jason P Van Batavia; Andrew J Combs
Journal:  Curr Urol Rep       Date:  2018-04-06       Impact factor: 3.092

Review 2.  Dysfunctional Voiders-Medication Versus Urotherapy?

Authors:  Angela M Arlen
Journal:  Curr Urol Rep       Date:  2017-02       Impact factor: 3.092

3.  The variation in urinary calcium levels in adult patients with fracture and surgical intervention.

Authors:  Junfei Wang; Xin Zheng; Liming Zhang; Yifan Zhang; Jin Xiong; Yixin Cheng; Hongfei Shi; Xusheng Qiu; Leqin Zhou; Xizhao Sun
Journal:  J Orthop Surg Res       Date:  2017-08-15       Impact factor: 2.359

Review 4.  Diagnosis and Management of Bladder Dysfunction in Neurologically Normal Children.

Authors:  Mirgon Fuentes; Juliana Magalhães; Ubirajara Barroso
Journal:  Front Pediatr       Date:  2019-07-25       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.